Top stories
Marketing & MediaARB clears Wildebeest Brandewyn ad accused of promoting binge drinking
Karabo Ledwaba 21 May 2026
Marketing & Media#CannesLions2026: Ad law and self-regulation summit debuts at Cannes Lions
15 May 2026
Subscribe & Follow
Advertise your job vacancies
Stanford study finds HIV drug can persist in mothers' milk
Stanford: A drug commonly used in the developing world to prevent transmission of HIV from mother to child persists in the breast milk and blood of the mothers, putting them and their babies at risk for developing drug-resistant strains of the virus, according to researchers at the Stanford University School of Medicine.
The researchers found that the drug, nevirapine, stays in the blood and breast milk of the infected mothers for at least two weeks. During that time, the virus has ample opportunity to transform itself into drug-resistant strains of HIV, the human immunodeficiency virus that causes AIDS, which can be very difficult to treat.
